Amarin Corporation plc (AMRN) Share Price Today, Stock Analysis, Annual Report | Value Research Amarin Corporation plc (AMRN) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial report.

Amarin Corporation plc (AMRN)

Download Stock Report

NASDAQ: AMRN

  • Price Change
  • Market Capitalisation market-capitalisation-info $522 Mln

  • 12 Month Earnings monthly-earning $-75 Mln
  • Price to Earnings price-to-earning --

Amarin Corporation plc (AMRN) Share Price

$0.91

As on 28-Sep-2023 16:00 EDT

up-down-arrow $-0.01-1.10%

  • Prev Close info

    $0.92

  • Day's Openinfo

    $0.89

  • Today's Highinfo

    $0.93

  • Today's Lowinfo

    $0.88

  • Today's Volumeinfo

    1,879,996

Please wait...

Amarin Corporation plc (AMRN) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Amarin (AMRN)
-24.80 -14.16 -21.56 -19.48 -37.96 -41.97 -17.91
S&P BSE Sensex*
8.20 1.28 2.99 16.31 20.12 12.69 12.81
#
-- -- -- -- -- -- --
As on 28-Sep-2023  |  *As on 29-Sep-2023  |  #As on
2022
2021
2020
2019
2018
2017
2016
Amarin (AMRN)
-64.09 -31.08 -77.19 57.53 237.15 30.19 62.96
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Amarin Corporation plc (AMRN) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Amarin Corporation plc (AMRN)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Pres, CEO & Director

        Mr. Karim Mikhail

        Pres of R&D, Exec. VP and Chief Scientific Officer

        Dr. Steven B. Ketchum Ph.D.

        Headquarters

        Dublin

        FAQs for Amarin Corporation plc (AMRN)

        The total asset value of Amarin Corporation plc (AMRN) stood at $ 1,104 Mln as on 31-Mar-23

        The share price of Amarin Corporation plc (AMRN) is $0.909900 (NASDAQ) as of 28-Sep-2023 16:00 EDT. Amarin Corporation plc (AMRN) has given a return of -37.96% in the last 3 years.

        Amarin Corporation plc (AMRN) has a market capitalisation of $ 522 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of Amarin Corporation plc (AMRN) is 0.80 times as on 02-Jun-2023, a -0.69% premium to its peers’ median range of 2.54 times.

        Since, TTM earnings of Amarin Corporation plc (AMRN) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Amarin Corporation plc (AMRN) and enter the required number of quantities and click on buy to purchase the shares of Amarin Corporation plc (AMRN).

        Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

        The CEO & director of Mr. Karim Mikhail. is Amarin Corporation plc (AMRN), and CFO & Sr. VP is Dr. Steven B. Ketchum Ph.D..

        The promoters of Amarin Corporation plc (AMRN) have pledged 0% of the total equity as on Dec-22.

        Amarin Corporation plc (AMRN) Ratios
        Return on equity(%)
        -15.47
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of Amarin Corporation plc (AMRN) was $-75 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $521.96 Mln
        • Revenue (TTM)revenue-information $360.54 Mln
        • Earnings (TTM) earning-information $-75.10 Mln
        • Cash date-information $304.37 Mln
        • Total Debt info $9.84 Mln
        • Insider's Holding 0.48%
        • Liquidity liquidity High
        • 52 Week range week-range $0.84 - 2.23
        • Shares outstanding share-outstanding 407,780,000
        • 10 Years Aggregate:

          CFO: $-824.49 Mln

          EBITDA: $-680.18 Mln

          Net Profit: $-747.17 Mln

        About The Company

        • IPO Date 01-Apr-1993
        • Pres, CEO & Director Mr. Karim Mikhail
        • Pres of R&D, Exec. VP and Chief Scientific Officer Dr. Steven B. Ketchum Ph.D.
        • Listing key-listing NASDAQ: AMRN
        • Country Ireland
        • Headquarters headquarters Dublin
        • Website website https://www.amarincorp.com
        • Business

          Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates....  It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon